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Cell cycle checkpoints coordinate a timely 
progression throughout the cell cycle that is 
fundamental to ensure that critical events such 
as DNA replication and chromosome segrega-
tion are completed accurately before cell divi-
sion takes place (1). The integrity of the process 
is verifi  ed both at the G1/S and G2/M transi-
tion boundaries as well as during S phase, with 
the resultant monitoring by a specifi  c check-
point pathway in each case. In response to 
DNA double-strand breaks (DSBs) and to-
gether with the assembly of the DNA repair 
complexes, cell cycle checkpoints are activated 
that either delay cell cycle progression until the 
breaks are repaired or promote apoptosis, de-
pending on the cell type and/or the amount of 
damage (2). Accordingly, the accumulation of 
genomic aberrations caused by the loss of cell 
cycle checkpoints has classically been inter-
preted as one of the motors that enables the in-
creased mutation rate necessary for cancer 
development (3). Moreover, recent data has 
showed that activation of the DNA damage 
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checkpoint is also triggered by oncogenic stress 
and is thus a conserved feature of early precan-
cerous lesions (4, 5). Besides cancer, a proper 
response to DNA breaks is also seminal to han-
dle the lesions generated during programmed 
recombination processes such as in meiosis or 
during V(D)J and class switch recombination 
reactions in lymphoid cells.
At the molecular level, activation of the 
DNA damage checkpoints is based on a phos-
phorylation cascade that starts with the ac-
tivation of certain members of the PIKK 
(phosphatidyl-inositol 3 kinaselike protein ki-
nase) family at the site of the lesion (6). Among 
the six PIKK proteins expressed in mammalian 
cells ataxia telangiectasia (AT) mutated (ATM) 
and ATM and Rad-3 related (ATR) are the 
two key members in triggering the DNA dam-
age transduction cascade and coordinating in-
dividual checkpoints. Although a third PIKK 
(DNA–PKcs) might also phosphorylate certain 
DNA damage response proteins in response to 
DSBs, its action seems more restricted to the 
break site and not in coordinating a global cel-
lular response (7). Our current understanding 
places ATM and ATR in two separate and al-
ternate pathways of checkpoint activation that 
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DNA double-strand breaks (DSBs) are among the most deleterious lesions that can chal-
lenge genomic integrity. Concomitant to the repair of the breaks, a rapid signaling cascade 
must be coordinated at the lesion site that leads to the activation of cell cycle checkpoints 
and/or apoptosis. In this context, ataxia telangiectasia mutated (ATM) and ATM and 
Rad-3–related (ATR) protein kinases are the earliest signaling molecules that are known 
to initiate the transduction cascade at damage sites. The current model places ATM and 
ATR in separate molecular routes that orchestrate distinct pathways of the checkpoint 
responses. Whereas ATM signals DSBs arising from ionizing radiation (IR) through a Chk2-
dependent pathway, ATR is activated in a variety of replication-linked DSBs and leads to 
activation of the checkpoints in a Chk1 kinase–dependent manner. However, activation of 
the G2/M checkpoint in response to IR escapes this accepted paradigm because it is depen-
dent on both ATM and ATR but independent of Chk2. Our data provides an explanation for 
this observation and places ATM activity upstream of ATR recruitment to IR-damaged 
chromatin. These data provide experimental evidence of an active cross talk between 
ATM and ATR signaling pathways in response to DNA damage.
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converge at the cyclin-dependent kinase (CDK) activity inhi-
bition step. On one hand, the response to DSBs such as those 
generated by ionizing radiation (IR) is triggered through 
ATM, and the signal is further amplifi  ed by ATM-dependent 
activation of the downstream kinase Chk2. On the other 
hand, an analogue pathway that works through ATR and 
the Chk2-relative Chk1 is accountable for the response to 
DSBs arising at replication forks. However, a detailed analy-
sis of the distinct eff  ects of ATM, ATR, Chk2, and Chk1 
defi  ciencies on checkpoint control challenges this simplistic 
view and implies that novel interactions among these kinases 
are necessary to explain the observed genetic requirements. 
Although ATM defi  ciency leads to the loss of control of all 
G1/S, intra-S, and G2/M checkpoints in response to IR (8), 
Chk2 knockout cells have no obvious defect in intra-S or 
G2/M checkpoint activation and show only a modest im-
pairment of the G1/S responses (9, 10). In contrast, although 
the ATR–Chk1 pathway is generally associated exclusively 
with replication-associated DSBs, both kinases are required 
for the IR-induced G2/M checkpoint (11, 12). In addition, 
phosphorylation of Chk1 is also detected in cells exposed to 
IR, but the interpretation of this result has classically been 
linked to the loss of specifi  city of ATM at high amounts of 
damage. In contrast with this view, we now have data show-
ing that this Chk1 phosphorylation in response to IR is the 
outcome of a fi  ne regulation that derives from the coordi-
nated action of both ATM and ATR. Our results demon-
strate that in response to IR, ATR is loaded onto chromatin 
Figure 1.  Analysis of ATM, Chk2, and Chk1 activation in response 
to DNA damage. (A) Western blot detection of ATM-1981P, ATM, Chk2-
T68P, Chk2, Chk1-S345P, and Chk1 in Raji human lymphoblastoid 
cells exposed to DNA-damaging conditions. Where indicated, ATM 
activity was inhibited by a previous 15-min treatment with 20 μM 
wortmannin (WM). (B) Evaluation of Chk1 phosphorylation dynamics 
in control and AT human cells in response to DNA damage. (C) West-
ern blot analysis of ATR, Chk1-S345P, Chk1, ATM-1981P, and ATM 
levels in extracts from control (ATRwt) and ATR   hypomorphic 
(ATRSeckel) human cells irradiated with 20 Gy (or mock irradiated [C]). 
β-actin levels were evaluated as a loading control. (D) Analysis of 
Chk1 phosphorylation in ATRflox/− cells 48 h after infection with 
Cre-expressing adenovirus (ATR∆/−) or mock infection (ATRflox/−). 
(E) The same analysis as in D, in which the loading was normalized 
to eliminate differences in total Chk1 levels. In all cases, exponen-
tially growing cells were irradiated with 20 Gy, and the   extracts 
were performed 45 min after irradiation (IR) or 2 h after exposure 
to 2 mM hydroxyurea (HU).JEM VOL. 203, February 20, 2006  299
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in an ATM-dependent manner that, for the fi  rst time, dem-
onstrates an active cross talk between ATM and ATR in 
the DNA damage response. Finally, the development of a 
new fl  ow cytometry–based detection assay for DNA damage 
signaling events has allowed us to discover that IR-induced 
Chk1 phosphorylation is restricted to late S and G2 cells, thus 
giving us a molecular framework to understand the series of 
events that govern the activation of the G2/M checkpoint.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
IR-induced Chk1 phosphorylation is dependent 
on ATM and ATR
To determine the molecular requirements that are respon-
sible for Chk1 phosphorylation in response to IR or to 
reagents that generate DSBs at the replication forks, we eval-
uated Chk1 phosphorylation at S345 by Western blotting in 
cells exposed to IR or hydroxyurea (HU). The experiment 
was carried in the presence or absence of the PIKK inhibi-
tor wortmannin at concentrations that have been reported to 
inhibit ATM but not ATR activity (Fig. 1 A; reference 13). 
The specifi  city of the inhibitor was validated by evaluating the 
levels of Chk2-T68 phosphorylation in the same conditions, 
which are strictly dependent on ATM (14, 15). In addition, 
the levels of ATM-1981P were also analyzed in our experi-
ments and served as a hallmark of ATM activation status (16).
The behavior of Chk2 phosphorylation was consistent with 
the current models and was found to be ATM dependent 
regardless of the DNA-damaging source. However, whereas 
Chk1-S345 phosphorylation is not dependent on ATM ac-
tivity in cells exposed to HU or aphidicolin (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20051923/
DC1), an event controlled primarily by ATR (12), the phos-
phorylation of Chk1 in response to IR was found to be ab-
rogated in cells pretreated with wortmannin. In agreement 
with this data, a similar regulation of Chk1 phosphorylation 
dynamics was observed in human ATM-defi  cient cells ob-
tained from patients of AT (Fig. 1 B). Analogous results were 
obtained with two additional AT cell lines (not depicted). In 
summary, these data imply that ATM activity is upstream of 
Chk1 phosphorylation in response to IR but not replication-
linked DSBs.
Because ATR and not ATM is responsible for Chk1-
S345 phosphorylation in response to stalled replication forks 
(12), we decided to evaluate the eff  ect of ATR defi  ciency in 
the Chk1 phosphorylation observed in response to radiation. 
To do this, IR-induced Chk1-345P levels were analyzed in 
lymphoblastoid cells derived from patients of a human he-
reditable disease known as the Seckel syndrome, which is 
Figure 2.  Nuclear retention of ATM and ATR in response to DSBs. 
(A) The association of ATM and ATR with chromatin in the various treat-
ments was evaluated in Raji cells by a serial fractionation protocol (see 
Materials and methods). Fraction I (cytoplasmic) and fraction III (chroma-
tin bound) are shown from the same extracts. ATM-1981P and Chk2-T68P 
levels are shown as controls of the wortmannin inhibitory effect. No 
 detectable  Chk2-T68P is bound to the chromatin with this protocol. The 
levels of the replication factor ORC2 are shown as a loading control in 
both cases because it is present both in the cytoplasmic as well as in a 
nuclear fraction. Notably, the association of ORC2 with chromatin does 
not change in response to DNA damage. The fi  gure illustrates the com-
mon observation of a set of experiments (n = 5). (B) Chromatin-bound 
fraction analysis in control and AT human cell lines. Treatments: C, con-
trol; IR, 20 Gy irradiation for 45 min; HU, 2 mM hydroxyurea for 2 h.300   ATM-DEPENDENT RECRUITMENT OF ATR TO DNA BREAKS | Cuadrado et al.
  associated with a dramatic reduction in ATR levels as a result 
of a synonymous mutation that alters the splicing effi   ciency 
of the transcript (Fig. 1 C; reference 17). Whereas IR- induced 
Chk1-S345P levels were readily detected in the correspond-
ing control line, almost no detectable signal was observed in 
ATR–Seckel cells. ATR-dependent phosphorylation of 
Chk1 in response to IR has also been observed in mouse em-
bryo fi  broblasts harboring conditional ATR alleles (11). To 
evaluate whether the Chk1 phosphorylation defect is not 
  directly dependent on ATR and is caused by an ineffi   cient 
activation of ATM in ATR–Seckel cells, IR-induced ATM-
1981P levels were analyzed in both cell lines. Notably, ATM 
phosphorylation is not aff  ected by the diminished levels of 
ATR found in ATR–Seckel cells, demonstrating that the 
ATR-dependent Chk1-S345 phosphorylation induced by 
IR occurs downstream of ATM activation. To avoid vari-
ability that might have arisen during the prolonged passages 
of the diff  erent cell lines, we evaluated the activation of Chk1 
in a previously published human cell line that is susceptible 
to ATR deletion upon infection with a Cre recombinase–
  expressing adenovirus (ATRfl  ox/−; Fig. 1 D; reference 18). 
Interestingly, in both experimental systems, we noted that 
ATR depletion leads to a concomitant decrease in Chk1 
  levels. Because, as reported previously (18), no diff  erences in 
cell cycle distribution were observed between ATRfl  ox/− and 
ATR∆/− cells in the cells used for our biochemical analyses, 
this observation might be indicative of an indirect role for 
ATR in the regulation of Chk1 levels as part of triggering 
the DNA damage response. To avoid these diff  erences and 
to directly evaluate the impact of ATR defi  ciency in Chk1 
Figure 3.  Analysis of RPA and ATR localization in response to DNA 
damage. (A) ATR immunostaining in control and AT cells exposed to DNA-
damaging conditions. Because most of the ATR pool is not bound to chro-
matin in the absence of damage and the in situ extraction eliminates this 
fraction, a gray mask based on the DAPI channel is drawn that indicates 
the presence of nuclei in each fi  eld. (B) Images of ATR and γ-H2AX signals 
in individual cells selected from A (arrows). (C) RPA immunostaining in 
control and AT cells. Equivalent to the biochemistry, exponentially growing 
cells were irradiated with 20 Gy, and the cells were processed 45 min after 
irradiation (IR) or 2 h after exposure to 2 mM   hydroxyurea (HU).JEM VOL. 203, February 20, 2006  301
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  phosphorylation, we normalized the loading by adjusting 
Chk1 levels between both cell lines (Fig. 1 E). The observa-
tions made in this conditional system are equivalent to the 
results obtained with Seckel cells and further demonstrate 
that Chk1 phosphorylation is controlled by ATR regardless 
of the type of damage. Altogether, our data demonstrates that 
whereas Chk1 activation in response to DSBs arising at stalled 
replication forks is strictly dependent on ATR, the phos-
phorylation of Chk1 in response to IR is coordinately regu-
lated by a sequential ATM→ATR–dependent pathway.
ATM regulates chromatin loading of ATR in response 
to DSBs
The aforementioned biochemical data suggest that ATR 
works downstream of ATM in the regulation of Chk1 after 
exposure to IR. Given that ATM is upstream of the accu-
mulation of several DSB repair/signaling proteins at damage 
sites, one potential explanation for our fi  ndings might occur 
if ATM is also involved in the redistribution of ATR onto 
damaged DNA. To evaluate this possibility, we fi  rst analyzed 
the chromatin loading of ATM and ATR in response to 
DNA damage by a nuclear fractionation technique (Fig. 2;
reference 19). As reported, exposure to IR induced the 
chromatin retention of a fraction of the ATM pool. Notably, 
whereas wortmannin pretreatment eliminated IR-  induced 
ATM-1981P foci (not depicted), it did not aff  ect the rapid 
chromatin loading of ATM in the same conditions, placing 
the global chromatin recruitment detected by this biochem-
ical assay upstream of the formation of foci. HU treatment 
also induces a noticeable retention of ATM in the chroma-
tin fraction, which was also unaff  ected upon ATM inhibi-
tion. From the simultaneous analysis of ATR recruitment 
to damaged chromatin, several conclusions can be obtained. 
First, extracts from HU and, to a lesser extent, IR triggered 
chromatin loading of ATR, demonstrating that the global 
chromatin retention in response to DNA damage previ-
ously observed for ATM is a conserved feature among early 
damage sensors. Strikingly, whereas the chromatin loading 
of ATR in response to HU was not diminished by ATM 
inactivation, IR-induced chromatin retention of ATR was 
severely abrogated in wortmannin-pretreated cells. Because 
the chromatin fractionation assay was performed 45  min 
after irradiation, no changes in cell cycle distribution are 
observed that could account for the diff   erences in ATR 
loading (Fig. S2, available at http://www.jem.org/cgi/ 
content/full/jem.20051923/DC1). Finally, and consistent 
with our inhibition data, the analysis of chromatin loading 
of ATR onto damaged chromatin in AT cells demonstrated 
that whereas ATR is loaded into chromatin in HU-treated 
cells, no IR-induced retention of ATR is present in the 
  absence of ATM (Fig. 2 B).
Equivalent to the biochemical fractionation technique 
used in Fig. 2, a protocol based on an in situ detergent pre-
extraction of the nucleoplasmic fraction allows for the micro-
scopical evaluation of chromatin-bound proteins in response 
to damage (20). Evaluation of ATR in AT and correspond-
ing control cell lines by these means confi  rmed that ATR is 
loaded onto chromatin in an ATM-dependent manner in re-
sponse to IR (Fig. 3 A). In agreement with our previous data, 
HU-induced ATR loading was not aff  ected by ATM status. 
Moreover, HU-induced loading of ATR was signifi  cantly 
higher than that obtained in response to IR and showed a 
pan-nuclear staining that contrasted with the foci-like pattern 
observed in irradiated cells. Where detectable, ATR signal 
colocalized with γ-H2AX, suggesting that the diff  erence in 
the staining pattern between IR- and HU-treated cells re-
fl  ects a global generation of DSBs in replicating cells in con-
trast with the localized damage generated by IR (Fig. 3 B). 
The analysis of RPA (replication protein A) localization 
showed that whereas RPA is chromatin bound regardless of 
DNA damage, it relocalizes into discrete foci upon exposure 
to IR or HU. Remarkably, RPA localization to DSBs showed 
the same ATM dependency as ATR, which provides evi-
dence that ATM regulation of ATR recruitment is medi-
ated at the earliest steps of activation of the ATR–Chk1 
pathway (Fig. 3 C). In summary, our data demonstrate that 
IR-induced chromatin loading of ATR is dependent on 
ATM activity and, thus, places ATM upstream of the 
ATR–Chk1 signaling pathway in the checkpoint responses 
initiated by radiation damage.
Figure 4.  Flow cytometry analysis of Chk1 and Chk2 phosphoryla-
tion during the cell cycle. An aliquot of the same Raji cells that were 
used for Western blotting (Fig. 1) or chromatin fractionation (Fig. 2) was 
analyzed in parallel with multiparametric fl  ow cytometry for DNA content 
with propidium iodide and for Chk1-S345P (A and B) or Chk2-T68P (C and 
D) levels with the corresponding specifi  c antibodies (see Materials and 
methods). Note the distinct increase in Chk1 phosphorylation in irradiated 
G2 cells (red asterisk). Dashed lines are incorporated in each case to illus-
trate the phosphorylation dynamics. Doses used: 20 Gy IR; 2 mM HU, 
and 20 μM wortmannin. C, control; PI, propidium iodide.302   ATM-DEPENDENT RECRUITMENT OF ATR TO DNA BREAKS | Cuadrado et al.
Cell cycle–specifi  c phosphorylation of Chk1 and Chk2 
in response to DNA damage
In contrast to ATM, cell cycle checkpoint activities of ATR 
and Chk1 are restricted to the S and G2 phases of the cell 
  cycle (11, 12, 21). Interestingly, IR-induced ATR and RPA 
foci are only detected in a fraction of the cells, suggesting that 
activation of this pathway could be constrained to certain 
stages of the cell cycle. To evaluate this possibility and taking 
advantage of a recent method that optimized the detection 
of phosphoepitopes by cytometry (22), we established a new 
fl  ow cytometry–based assay that allowed us to analyze the 
levels of Chk1 and Chk2 phosphorylation in each stage of the 
cell cycle. The results illustrated in Fig. 4 gave us a compre-
hensive picture of the cell cycle–dependent Chk1 and Chk2 
phosphorylation profi   les in response to DNA damage. 
Whereas an increase in Chk2-T68P levels was detected in all 
stages of the cell cycle in response to IR, this increase was 
  restricted to the S phase in HU-treated cells. This behavior is 
expected because in contrast to the unbiased nature of IR, 
the capacity of HU to generate DSBs is only present in repli-
cating cells. Moreover (and consistent with the Western blot 
data), both IR- and HU-induced Chk2 phosphorylation 
were abrogated in cells pretreated with ATM-inhibiting 
doses of wortmannin. Thus, ATM-dependent Chk2 phos-
phorylation is triggered whenever a DSB is detected, regard-
less of the damaging source or the cell cycle stage. The 
analysis of Chk1-S345 phosphorylation dynamics by the same 
means produced a clarifying result. Similar to Chk2-T68P, 
HU-  induced Chk1 phosphorylation was only detected in 
replicating cells. Surprisingly, a similar behavior was found 
in response to IR, with the remarkable diff  erence that Chk1 
phosphorylation was most prominent in irradiated G2 cells. 
Furthermore (and consistent with the biochemical data pre-
sented in Fig. 1), Chk1 phosphorylation in S-G2 was abro-
gated in the absence of ATM activity. In summary, these 
results provide a direct explanation for the restricted role of 
Chk1 to S and G2 phases of the cell cycle in response to IR 
and present a comprehensive view of ATM and ATR activ-
ities throughout the cell cycle.
A new model for ATM/ATR/Chk1 functions in response 
to DSBs
The current data suggests a new model for the control of IR-
induced checkpoint signaling pathways for the diff  erent stages 
of the cell cycle depicted in Fig. 5. In response to IR, ATM 
phosphorylates Chk2 throughout the cell cycle, which might 
particularly enhance the regulation of the G1 checkpoint 
through regulating p53 phosphorylation status. In S phase, 
both ATM and ATR coordinate checkpoint activities. On 
one hand, in response to reagents that promote stalled replica-
tion forks such as HU or aphidicolin, an ATR–Chk1 cascade 
is eff  ective that is not dependent on ATM activity. Notably, 
a signifi  cantly higher loading of ATR onto the chromatin of 
HU-treated cells is detected in the absence of ATM activity 
(Fig. 2 A). This fi  nding is in agreement with our model, and 
because HU triggers both ATM and ATR activities through 
independent pathways, it could be the outcome of compensa-
tory loading of ATR in the absence of ATM. On the other 
hand, IR-induced ATM-dependent checkpoint signaling in 
S phase is mediated by a diff  erent set of eff  ectors such as Nbs1 
or Smc1 that regulate replication dynamics of damaged DNA 
independently of Chk2. In addition, in irradiated S and G2 
cells, ATM coordinates the activation of Chk1 through the 
recruitment of ATR to the damaged chromatin, which, in 
turn, regulates IR-induced checkpoint responses. The S/G2 
specifi  city of this pathway is reminiscent of the kinase activ-
ity of CDKs. In fact, a recent publication has shown that the 
use of a broad spectrum CDK inhibitor inhibits IR-induced 
Chk1 phosphorylation (23). However, it is still unclear how 
CDK activity is linked to the activation of this pathway. 
Regardless of the cell cycle specifi  city, our results demon-
strate an active cross talk between ATM and ATR signaling 
pathways that cooperate in the molecular cascade that controls 
checkpoint signaling in postreplicative mammalian cells.
MATERIALS AND METHODS
Cell lines. Raji (CCL-86) and ATRfl  ox/− (CRL-2780) human cell lines 
were purchased from the American Type Culture Collection. ATR wild-
type (GM12072), ATR–Seckel (GM18367), ATM wild-type (GM00367), 
and AT (GM09607) cell lines were obtained from the Coriell Cell Reposi-
tories. Additional wild-type and AT lymphoblastoid lines were gifts of 
Y. Shiloh (Tel Aviv University, Tel Aviv, Israel). In the case of ATRfl  ox/− 
cells, biochemistry was performed 48–60 h after infection with adenovirus 
Cre. As reported previously (18), no detectable diff   erences in cell cycle 
  distribution were identifi  ed at these times after infection (unpublished data).
Figure 5.  Interactions between ATM, ATR, Chk2, and Chk1 in the 
DNA damage response. The diagram illustrates the molecular determi-
nants that control the responses to IR and HU initiated in the different 
stages of the cell cycle. Whereas ATR and Chk1 activities in checkpoint 
signaling are restricted to cells beyond S phase, ATM activity is necessary 
throughout the cell cycle.JEM VOL. 203, February 20, 2006  303
BRIEF DEFINITIVE REPORT
Chromatin-bound fractionation and immunoblotting. The details of 
this protocol have been reported previously (19). In brief,  107 cells were fi  rst 
resuspended for 5 min on ice in 150 μl of fractionation buff  er (50 mM Hepes, 
pH 7.5, 150 mM NaCl, and 1 mM EDTA) containing 0.04% Nonidet P-40 
supplemented with protease and phosphatase inhibitors. After centrifugation, 
the supernatant was collected (fraction I), and pellets containing all of the 
nuclei were washed twice with the same buff  er. Nuclear pellets were further 
extracted for 40 min on ice with 150 μl of fractionation buff  er containing 
0.5% Nonidet P-40. The extracts were clarifi  ed by centrifugation at 16,000 g 
for 15 min (chromatin-bound fraction). Aliquots of each fraction derived 
from equivalent cell numbers were separated on 4–12% SDS-PAGE gels and 
blotted onto polyvinylidene difl  uoride membranes. Equal loading of fractions 
from treated and untreated samples was verifi  ed by immunoblotting against 
the nuclear factor ORC2 (a gift of J. Mendez, Spanish National Cancer 
  Center, Madrid, Spain). ATM-1981P (Rockland Immunochemicals, Inc.), 
ATM (Novus Biologicals), ATR (Serotec), Chk2 (Upstate Biotechnology), 
Chk1 (Novocastra), β-actin (Sigma-Aldrich), Chk2-T68P, and Chk1-S345P 
(Cell Signaling Technology) primary antibodies were used in this study.
Flow cytometry of DNA damage-induced phosphorylation events. 
Our protocol is a variation of a recent method used to evaluate phosphoepi-
tope status by fl  ow cytometry (22). 5 × 105 cells were fi  xed by adding form-
aldehyde directly into the culture medium to obtain a fi  nal concentration of 
1.5%. Cells were incubated in fi  xative for 10 min at room temperature and 
collected by centrifugation. They were then permeabilized by resuspending 
with vigorous vortexing in 500 μl of ice-cold MeOH and incubated at 4°C 
for 10 min. Cells were washed twice in staining media (PBS containing 1% 
BSA), resuspended in staining media containing Chk2-T68P or Chk1-S345P 
primary antibodies (Cell Signaling Technology), and incubated for 1 h 
at room temperature. After washing and repeating the process with 
AlexaFluor488-conjugated secondary antibodies (Invitrogen), the cells 
were fi  nally resuspended in staining media containing 5 μg/ml propidium 
iodide and incubated for 20 min at 37°C. Flow cytometry was evaluated 
in a FACScanner (Beckton Dickinson).
Immunocytochemistry. Cells were seeded onto an 18-mm2 coverslip and 
were exposed to DNA damaging conditions 24 h later. 45 (IR) or 120 (HU) 
min after the exposure, cells were processed with a previously reported in 
situ fractionation technique (20) and stained with ATR (Santa Cruz Bio-
technology, Inc.), γ-H2AX (Upstate Biotechnology), and RPA (Rockland 
Immunochemicals, Inc.) recognizing primary antibodies. AlexaFluor488- 
and 568-conjugated secondary antibodies were obtained from Invitrogen. 
DNA was counterstained with DAPI.
Online supplemental material. Fig. S1 shows the specifi  city of wortman-
nin-mediated inhibition of ATM. Fig. S2 shows the cell cycle distribution 
analysis of irradiated Raji cells in the presence or absence of wortmannin 
45 min after exposure to the radiation source. Where indicated in these fi  g-
ures, ATM activity was inhibited by a previous 15-min treatment with 
20 μM wortmannin. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20051923/DC1.
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